Power of Biosimilars
BSS believes that high-quality care doesn’t have to come at high cost. Biosimilar therapeutics that closely replicate more expensive biologics can set new standards for value—something patients, providers, and payers are demanding across the healthcare continuum. Our therapies are placing the benefits of costly biologics within reach for patients, including those who had little or no access in the past.
The Benefits of Biosimilars
Biosimilars are safe, effective, and affordable alternatives to existing brand biologics that meet the same standards set by the US Food and Drug Administration (FDA). They have the potential to offset the burdens of rising costs and diminishing access to care.
The introduction of biosimilars has led to lower prices and is expected to relieve pressure to the healthcare system through decreases in hospitalization and ambulatory care. Most importantly, biosimilars have increased access to life-altering treatments for patients by offering high-quality and affordable therapeutic options, which may free-up resources for other important aspects of healthcare.